Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

At its height, NAIAS in Detroit was truly an international show, where anyone involved in the auto industry was expected to ...

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari Medical.

New techniques and devices made headway in tough treatment scenarios, and guidelines stressed the need for collaborative care ...

portfolio with the launch of its R2P NaviCross peripheral support catheter in the United States. Inari’s ClotTriever Thrombectomy System Gains Reimbursement Approval in Japan December 2, 2024—Inari ...